NO20006381L - Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler - Google Patents

Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Info

Publication number
NO20006381L
NO20006381L NO20006381A NO20006381A NO20006381L NO 20006381 L NO20006381 L NO 20006381L NO 20006381 A NO20006381 A NO 20006381A NO 20006381 A NO20006381 A NO 20006381A NO 20006381 L NO20006381 L NO 20006381L
Authority
NO
Norway
Prior art keywords
compositions
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
NO20006381A
Other languages
English (en)
Other versions
NO20006381D0 (no
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006381L publication Critical patent/NO20006381L/no
Publication of NO20006381D0 publication Critical patent/NO20006381D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet farmasøytiske kombinasjonssammensetninger og fremgangsmåter omfattende (-)-cis-6-fenyl-5-(4-(2-pyrrolidin-1 -yl-etoksy)-fenyl)-S.ej.S-tetrahydronaftalen^-ol eller et farmasøytiskakseptabelt salt derav og 2-amino-N-(1(RH2,4-difluor-benzyloksymetyl)-2okso-2-(3-okso-3a(R)-pyirdin-2-yl-metyl^^^^-tnfluortyl^.a.aa^.ej-heksahydro-pyrazol^^cjpyridin-S-yl)-etyl)-2-metyl-propionamid eller et farmasøytisk akseptabelt salt derav, fremgangsmåter for anvendelse.av slike sammensetninger og settinneholdende slike. sammensetninger. Sammensetningene er nyttige for behandling av muskel-skjelettsvakhet, inkludert osteoporose, osteoporotiske brudd, lav benmasse, skjørhet og lav muskelmasse.
NO20006381A 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler NO20006381D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006381L true NO20006381L (no) 2000-12-14
NO20006381D0 NO20006381D0 (no) 2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006381A NO20006381D0 (no) 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Country Status (29)

Country Link
EP (1) EP1085867A1 (no)
JP (1) JP2002518328A (no)
KR (1) KR20010052817A (no)
CN (1) CN1305378A (no)
AP (1) AP9901581A0 (no)
AR (1) AR018868A1 (no)
AU (1) AU3342099A (no)
BG (1) BG105128A (no)
BR (1) BR9911357A (no)
CA (1) CA2335112A1 (no)
CO (1) CO5070586A1 (no)
EA (1) EA200001189A1 (no)
GT (1) GT199900083A (no)
HR (1) HRP20000857A2 (no)
HU (1) HUP0102395A2 (no)
ID (1) ID26726A (no)
IL (1) IL139587A0 (no)
IS (1) IS5727A (no)
MA (1) MA26648A1 (no)
NO (1) NO20006381D0 (no)
OA (1) OA11569A (no)
PA (1) PA8472101A1 (no)
PE (1) PE20000633A1 (no)
PL (1) PL345064A1 (no)
SK (1) SK18902000A3 (no)
TN (1) TNSN99118A1 (no)
UY (1) UY25557A1 (no)
WO (1) WO1999065488A1 (no)
ZA (1) ZA993973B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
IL162144A0 (en) * 2001-11-29 2005-11-20 Gtx Inc Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
CO5070586A1 (es) 2001-08-28
HRP20000857A2 (en) 2001-10-31
PL345064A1 (en) 2001-11-19
PE20000633A1 (es) 2000-07-26
EP1085867A1 (en) 2001-03-28
CN1305378A (zh) 2001-07-25
AU3342099A (en) 2000-01-05
OA11569A (en) 2004-07-01
IL139587A0 (en) 2002-02-10
ZA993973B (en) 2000-12-15
IS5727A (is) 2000-11-24
PA8472101A1 (es) 2000-09-29
TNSN99118A1 (fr) 2005-11-10
ID26726A (id) 2001-02-01
EA200001189A1 (ru) 2001-06-25
CA2335112A1 (en) 1999-12-23
SK18902000A3 (sk) 2001-12-03
HUP0102395A2 (hu) 2001-11-28
JP2002518328A (ja) 2002-06-25
UY25557A1 (es) 2001-01-31
BR9911357A (pt) 2001-03-13
BG105128A (en) 2001-11-30
AR018868A1 (es) 2001-12-12
NO20006381D0 (no) 2000-12-14
MA26648A1 (fr) 2004-12-20
WO1999065488A1 (en) 1999-12-23
AP9901581A0 (en) 1999-06-30
GT199900083A (es) 2000-12-05
KR20010052817A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
AU2001258138A1 (en) Bone plate for the fixation of fractures of the proximal humerus
SI1389963T1 (sl) Kostna ploscica za fiksiranje zlomov proksimalnega humerusa
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
AU651369B2 (en) Method and apparatus for the fixation of bone fractures, limb lengthening and the correction of deformities
YU7797A (sh) Kombinovana terapija za osteoporozu
EA200600228A1 (ru) Лечение нарушений костной ткани с использованием селективных модуляторов адрогенных рецепторов
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
NO20006381L (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
DE3851776D1 (de) Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
AP9801269A0 (en) Prostaglandin agonists.
DK0937478T3 (da) Indretning og apparat til intrakavitær indgivelse af lægemidler under videounderstøttet kirurgi eller anden endoskopisk fremgangsmåde
WO2001043733A3 (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
BG105125A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
EP1420827B8 (en) 5-cnac as oral delivery agent for parathyroid hormone fragments
NO20006312L (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
NO991589D0 (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
PT966968E (pt) Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2
Damsin The Ilizarov technique: a method criticised but valued
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
ECSP993016A (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratoroidea
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
AU2001265248A1 (en) Measurement of the therapeutic dose for bone marrow ablation therapy
TH57984A3 (th) การรวมในทางการรักษาซี่งประกอบด้วยตัวปรับตัวรับเอสโตรเจนแบบคัดเลือกและฮอร์โมนพาราไธรอยด์
RU2003125500A (ru) Способ лечения переломов проксимального отдела бедренной кости с отрывом малого вертела при коксартрозе
TH48282A (th) การรักษาโรคของการให้ยาประกอบร่วมกันของโรคกระดูกพรุน

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application